Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis... von Shebl, Amgad, Gabriel, Susie, Van Dinther, Kristy, Hubsch, Alphonse, Lawo, John‐Philip, Hoefferer, Liane, Welsh, Susan

Volltext

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor von Longhurst, Hilary, Cicardi, Marco, Craig, Timothy, Bork, Konrad, Grattan, Clive, Baker, James, Li, Huamin H, Reshef, Avner, Bonner, James, Bernstein, Jonathan A, Anderson, John, Lumry, William R, Farkas, Henriette, Katelaris, Constance H, Sussman, Gordon L, Jacobs, Joshua, Riedl, Marc, Manning, Michael E, Hebert, Jacques, Keith, Paul K, Kivity, Shmuel, Neri, Sergio, Levy, Donald S, Baeza, Maria L, Nathan, Robert, Schwartz, Lawrence B, Caballero, Teresa, Yang, William, Crisan, Ioana, Hernandez, María D, Hussain, Iftikhar, Tarzi, Michael, Ritchie, Bruce, Králíčková, Pavlina, Guilarte, Mar, Rehman, Syed M, Banerji, Aleena, Gower, Richard G, Bensen-Kennedy, Debra, Edelman, Jonathan, Feuersenger, Henrike, Lawo, John-Philip, Machnig, Thomas, Pawaskar, Dipti, Pragst, Ingo, Zuraw, Bruce L

Volltext

Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study von Fukuda, Tomoo, Yamagami, Keiko, Kawahata, Kimito, Suzuki, Yuzo, Sasaki, Yoshihiro, Miyagi, Takashi, Jacobs, Iris, Lawo, John-Philip, Glassman, Fiona, Akama, Hideto, Hide, Michihiro, Ohsawa, Isao

Volltext

Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency von Rojavin, Mikhail A., Hubsch, Alphonse, Lawo, John-Philip

Volltext

Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans von Hofbauer, Christoph J., Whelan, ShawnF.J., Hirschler, Maria, Allacher, Peter, Horling, Frank M., Lawo, John-Philip, Oldenburg, Johannes, Tiede, Andreas, Male, Christoph, Windyga, Jerzy, Greinacher, Andreas, Knöbl, Paul N., Schrenk, Gerald, Koehn, Jadranka, Scheiflinger, Friedrich, Reipert, Birgit M.

Volltext

Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema von Lumry, William R., Craig, Timothy, Zuraw, Bruce, Longhurst, Hilary, Baker, James, Li, H. Henry, Bernstein, Jonathan A., Anderson, John, Riedl, Marc A., Manning, Michael E., Keith, Paul K., Levy, Donald S., Caballero, Teresa, Banerji, Aleena, Gower, Richard G., Farkas, Henriette, Lawo, John-Philip, Pragst, Ingo, Machnig, Thomas, Watson, Douglas J.

Volltext

Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials von Jolles, Stephen, Rojavin, Mikhail A., Lawo, John-Philip, Nelson, Robert, Wasserman, Richard L., Borte, Michael, Tortorici, Michael A., Imai, Kohsuke, Kanegane, Hirokazu

Volltext

Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropath... von Merkies, Ingemar S. J., van Schaik, Ivo N., Bril, Vera, Hartung, Hans‐Peter, Lewis, Richard A., Sobue, Gen, Lawo, John‐Philip, Mielke, Orell, Cornblath, David R.

Volltext

Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from t... von Lumry, William R., Zuraw, Bruce, Cicardi, Marco, Craig, Timothy, Anderson, John, Banerji, Aleena, Bernstein, Jonathan A., Caballero, Teresa, Farkas, Henriette, Gower, Richard G., Keith, Paul K., Levy, Donald S., Li, H. Henry, Magerl, Markus, Manning, Michael, Riedl, Marc A., Lawo, John-Philip, Prusty, Subhransu, Machnig, Thomas, Longhurst, Hilary

Volltext

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy von Tortorici, Michael A., Yuraszeck, Theresa, Cornblath, David, Bril, Vera, Hartung, Hans‐Peter, Sobue, Gen, Lewis, Richard A., Merkies, Ingemar S. J., Lawo, John‐Philip, Praus, Michaela, Durn, Billie L., Mielke, Orell, Ma, Xuewen, Jauslin, Petra, Pfister, Marc, Schaik, Ivo N.

Volltext

Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease von Jolles, Stephen, Borte, Michael, Nelson, Robert P, Rojavin, Mikhail, Bexon, Martin, Lawo, John-Philip, Wasserman, Richard L

Volltext

Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks von Bernstein, Jonathan A, Li, Huamin Henry, Craig, Timothy J, Manning, Michael E, Lawo, John-Philip, Machnig, Thomas, Krishnarajah, Girishanthy, Fridman, Moshe

Volltext

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneur... von Mielke, Orell, Cornblath, David R., Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Durn, Billie, Shebl, Amgad, George, K., Roberts, L., Carne, R., Henderson, R., Van Damme, P., Larue, S., D'Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T., Rubanovits, I., Gross‐Paju, K., Sorro, U., Auranen, M., Pouget, J., Le Masson, G., Wielanek‐Bachelet, A., Desnuelle, C., Clavelou, P., Aufauvre, D., Schmidt, J., Sommer, C., Kramer, D., Goerlitz, C., Haas, J., Gold, R., Berlit, P., Jaspert‐Grehl, A., Liebetanz, D., Kutschenko, A., Stangel, M., Trebst, C., Bergh, F., Klehmet, J., Klostermann, F., Oechtering, J., Lehmann, H., Bethke, F., Drory, V., Yarnitsky, D., Di Muzio, A., Sorbi, S., Mata, S., Grandis, M., Lauria, G., Antonini, G., Morino, S., Zibetti, M., Kanda, T., Kaida, K., Onoue, H., Mori, M., Iijima, M., Tomiyama, M., Akutsu, T., Yokoyama, K., Kanai, K., Eftimov, F., Notermans, N.C., Visser, N., Hoeijmakers, J., Rejdak, K., Chyrchel‐Paszkiewicz, U., Antonia, M., Salvado, M., Infante, C. Marquez, Benitez, S., Lunn, M., Morrow, J., Lavin, T., Melamed, I., Testori, A., Menichella, D., Simpson, E., Dimachkie, M., Beydoun, S., Lange, D., Shtilbans, A., Ladha, S., Freimer, M., Kissel, J., Rao, T., MacDonald, P., Sharma, K., Gonzalez, G., Allen, J., Walk, D., Hobson‐Webb, L., Gable, K.

Volltext

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single-Dose Administration in Healthy Japanese and White Adults von Glassman, Fiona, Lawo, John-Philip, Bica, Mihai Alexandru, Roberts, Anthony, Pawaskar, Dipti, Akama, Hideto, Jain, Meena, Goodson, Summer

Volltext

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial von Merkies, Ingemar S. J., Lawo, John‐Philip, Edelman, Jonathan M., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Léger, Jean‐Marc, De Bleecker, J. L., Robberecht, W., Saarela, M., Franques, J., Léger, J.‐M., Juntas Morales, R., Sommer, C., Nguento, A., Schmidt, J., Schrey, Ch, Kamienowski, J., Stelmasiak, Z., Zwolińska, G.

Volltext

Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks von Staubach, Petra, Tachdjian, Raffi, Li, H Henry, Hakl, Roman, Aygören-Pürsün, Emel, Wieman, Lolis, Lawo, John-Philip, Craig, Timothy J

Volltext

Electrophysiological predictors of response to subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy von Alcantara, Monica, Hartung, Hans-Peter, Lawo, John-Philip, Durn, Billie L., Mielke, Orell, Bril, Vera

Volltext

Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study von Reshef, Avner, Hsu, Connie, Katelaris, Constance H, Li, Philip H, Magerl, Markus, Yamagami, Keiko, Guilarte, Mar, Keith, Paul K, Bernstein, Jonathan A, Lawo, John-Philip, Shetty, Harsha, Pollen, Maressa, Wieman, Lolis, Craig, Tim J

Volltext

Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra... von Bril, Vera, Hartung, Hans-Peter, Lawo, John-Philip, Durn, Billie L., Mielke, Orell

Volltext

Privigen® has similar pharmacokinetic properties in primary and secondary immune deficiency von Tortorici, Michael A., Lawo, John-Philip, Weide, Rudolf, Jochems, Jeanine, Puli, Shilpa, Hofmann, Jutta, Pfruender, Dietmar, Rojavin, Mikhail A.

Volltext